Global Cholesterol Testing Services Market, By
Age Group (Geriatric, Adults, and Pediatric), By Service Provider (Hospitals,
Diagnostic Laboratories, Ambulatory Care Centers, and Others) and by Region
(North America, Latin America, Europe, Asia Pacific, the Middle East, and
Africa) was valued at US$ 11.5 Bn in 2016 and is projected to exhibit a CAGR of
7.8% over the forecast period (2017–2025), as highlighted in a new report
published by Coherent Market Insights. Increasing prevalence of high
cholesterol level is expected to drive growth of global cholesterol testing
services market in the near future.
Browse 27 Market Data Tables and 36 Figures
spread through 175 Pages and in-depth TOC on Cholesterol Testing Services
Market by Age Group (Geriatric, Adults, and Pediatric), By Service Provider
(Hospitals, Diagnostic Laboratories, Ambulatory Care Centers, and Others), and
Region (North America, Latin America, Europe, Asia Pacific, the Middle East,
and Africa) - Global Forecast to 2025
To get holistic SAMPLE of the report: https://www.coherentmarketinsights.com/insight/request-sample/1376
According to a research published by National
Heart Foundation of Australia, in 2012, around 5.6 million people aged 18 years
and above were reported to have high total cholesterol levels in Australia.
High blood cholesterol could lead to risk for developing various heart diseases
and stroke, owing to which, people are opting for regular cholesterol checkups.
This is expected to increase demand for its testing thus, driving growth of the
market in the near future. Furthermore, cholesterol level in plasma increases
with age, according to a study published in NCBI in 2013. Hence, rising
geriatric population and increasing prevalence of obesity are also expected to
be factors aiding in market growth. This is due to high susceptibility of obese
and geriatric population to increasing cholesterol levels. For instance,
according to a study published by World Health Organization (WHO) in 2014,
globally, over 1.9 billion adults aged 18 years and above were overweight, from
which over 600 million adults were obese. According to National Institute of
Health (NIH) in 2016, around 8.5%, which is 617 million of the world
population, is aged 65 and above.
New developments in cholesterol testing,
through R&D is expected to be a key factor for growth of the market. For
instance, in 2013, researchers at John Hopkins University developed new method
for calculating LDL, or low-density lipoprotein. This new method, to calculate
LDL (bad cholesterol levels) in the blood, has eliminated inconvenient pre-test
fasting. This research also provided evidence that the new method of
calculating bad cholesterol levels in the blood is more accurate than the
conventional method. Furthermore, key players in the market are focusing on
launching new devices for cholesterol testing and this is also expected to
drive growth of the global cholesterol testing services market in the near
future. For instance, in 2013, ACON Laboratories, Inc. launched its mission
cholesterol monitoring system for complete lipid panel testing. This
cholesterol monitoring system offers cholesterol testing at relatively low
costs.
Request a
Customization: https://www.coherentmarketinsights.com/insight/request-customization/1376
Key
Takeaways of the Cholesterol Testing Services Market:
·
The
global cholesterol testing services market is expected to exhibit a CAGR of
7.8% over the forecast period (2017–2025), owing to increasing prevalence of
high cholesterol level with rising incidence of obesity, and increasing
geriatric population.
·
North
America was the dominant region in the global cholesterol testing services
market and is expected to retain its dominance over the forecast period
(2017–2025). This is owing to increasing prevalence of high cholesterol levels
among the population, especially in adults and aged, in the U.S.
·
Key
players are focusing on expanding their presence by launching new devices &
systems and receiving marketing approvals for their new products in key
geographies.
·
Major
players operating in the cholesterol testing services market include Quest
Diagnostics Incorporated, Spectra Laboratories Inc., Bio-Reference Laboratories
Inc., Eurofins Scientific (Luxembourg), Clinical Reference Laboratory, Inc.
(CRL), ACM Medical Laboratory, Adicon Clinical Laboratory, Unilabs, SYNLAB
International GmbH, and Laboratory Corporation of America Holdings (LabCorp).
About CMI
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
No comments:
Post a Comment